# POST_MARKET_MODEL_SURVEILLANCE_REPORTING.md
**Post-Deployment AI Model Monitoring & Reporting Framework**

---

## 1. Purpose

This document defines the **post-market surveillance and reporting requirements** for all AI models deployed within the NeuroGrid ecosystem.

Its objectives are to:
- Detect safety, performance, and compliance issues after deployment
- Ensure continuous regulatory alignment
- Enable early identification of adverse trends
- Maintain public and institutional trust in clinical AI systems

Post-market surveillance is treated as a **regulatory and patient-safety obligation**, not a performance optimization activity.

---

## 2. Scope

This framework applies to:
- All AI models deployed in clinical or RPM contexts
- All MedIntel inference pipelines
- All models registered via DeSci governance
- All updates, retraining events, and configuration changes

It spans **Core auditability**, **MedIntel execution**, and **DeSci compliance oversight**.

---

## 3. Surveillance Objectives

Post-market surveillance must achieve:
1. Early detection of safety risks
2. Identification of model drift or degradation
3. Verification of intended-use adherence
4. Detection of unintended behaviors
5. Regulatory-ready evidence generation

---

## 4. Mandatory Monitoring Dimensions

All deployed models must be monitored across the following dimensions:

### 4.1 Safety Signals
- Adverse event correlations
- False negative escalation events
- Alert suppression anomalies
- Emergency override frequency

### 4.2 Performance Metrics
- Accuracy and precision trends
- Sensitivity and specificity
- Confidence score stability
- Error distribution shifts

### 4.3 Clinical Alignment
- Concordance with clinician decisions
- Override rates and rationale
- Missed escalation reviews

### 4.4 Operational Integrity
- Data pipeline continuity
- Input signal quality
- Latency and availability metrics

---

## 5. Reporting Triggers

Surveillance reports must be generated when:
- Safety thresholds are breached
- Performance deviates beyond approved limits
- Model drift is detected
- Significant configuration changes occur
- Regulatory authorities request disclosure

Critical events require **immediate reporting**.

---

## 6. Reporting Frequency

| Report Type | Frequency |
|-----------|-----------|
| Routine Surveillance Summary | Quarterly |
| Safety Signal Review | Monthly |
| Drift Assessment | Continuous |
| Adverse Event Report | Immediate |
| Regulatory Disclosure | As required |

---

## 7. Report Contents

Each surveillance report must include:
- Model identifier and version
- Deployment context
- Monitoring period
- Detected issues (if any)
- Impact assessment
- Corrective or preventive actions
- Status of remediation

Patient-identifiable data is **strictly excluded**.

---

## 8. Escalation & Remediation

If surveillance identifies a material risk:
- Model escalation protocols are triggered
- Ethics and compliance review is mandatory
- Deployment suspension may occur
- Model rollback or retirement may be required

All actions must be logged and auditable.

---

## 9. Audit & Traceability

Surveillance activities must be:
- Fully traceable to model versions
- Linked to change control records
- Retained per governance record policies
- Accessible for independent audit

---

## 10. Prohibited Practices

The following are prohibited:
- Ignoring negative surveillance signals
- Selective reporting of favorable data
- Delaying disclosures for reputational reasons
- Modifying monitoring criteria without approval
- Using surveillance data for marketing claims

---

## 11. Regulatory Alignment

This framework aligns with:
- EU MDR post-market surveillance requirements
- FDA SaMD post-market guidance
- EU AI Act lifecycle monitoring obligations
- ISO 14971 risk management
- ISO/IEC 62304 software lifecycle standards

---

## 12. Ethical Position

> **Deployment is not the end of responsibility;  
> it is the beginning of accountability.**

Continuous surveillance is essential to ethical clinical AI.

---

## 13. Binding Status

This document is:
- Mandatory for all deployed models
- Enforced through compliance mechanisms
- Subject to regulatory inspection
- Amendable only via approved governance process

---

### Status
**Active – Post-Market Model Surveillance & Reporting Framework**

